Inactive Instrument

Highlights Quest PharmaTech Inc. Other OTC

Equities

QPTFF

CA74836M1068

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis	24/01	MT
Quest PharmaTech Inc. Receives Recommendations from the Data Safety Monitoring Board to Discontinue Oregovomab Phase III Clinical Study	24/01	CI
Quest PharmaTech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	14/12	CI
Quest PharmaTech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	21/23/21	CI
Quest PharmaTech Provided Product Development Update	11/23/11	MT
Quest PharmaTech Inc. Provides Product Development Update	11/23/11	CI
Quest PharmaTech Inc. Reports Earnings Results for the First Quarter Ended April 30, 2023	29/23/29	CI
Quest PharmaTech Inc. Reports Earnings Results for the Full Year Ended January 31, 2023	01/23/01	CI
Quest PharmaTech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022	19/22/19	CI
Quest PharmaTech Details Bioceltran Interest Sale, Return of Photodynamic Therapy Technology License	29/22/29	MT
Sang Ho Jang acquired unknown minority stake in Bioceltran Co., Ltd from Quest PharmaTech Inc. for CAD 0.3 million.	28/22/28	CI
Quest PharmaTech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022	27/22/27	CI
Quest PharmaTech Inc. Reports Earnings Results for the First Quarter Ended April 30, 2022	28/22/28	CI
Quest PharmaTech Inc. Reports Earnings Results for the Full Year Ended January 31, 2022	27/22/27	CI
Quest PharmaTech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2021	23/21/23	CI
Quest Pharmatech Inc. Reports Earnings Results for the Second Quarter Ended July 31, 2021	24/21/24	CI
Quest Pharmatech Inc. Reports Earnings Results for the First Quarter Ended April 30, 2021	23/21/23	CI
Quest Pharmatech Inc. Reports Earnings Results for the Full Year Ended January 31, 2021	31/21/31	CI
Quest PharmaTech : Provides Update on Asset Transfer Between OncoQuest and OncoQuest Pharmaceuticals	06/21/06	MT
Quest Pharmatech Inc. Reports Earnings Results for the Third Quarter Ended October 31, 2020	23/20/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Quest PharmaTech Inc. Other OTC

Equities

QPTFF

CA74836M1068

Highlights

Filters